Calum Purdie
Research Subjects
Calum Purdie has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Callum George Fraser
Population Health and Genomics , Ninewells Hospital and Medical School, University of Dundee , Dundee , UK
1 shared publication David A. Cameron
Univ Edinburgh, Inst Genet & Canc, Western Gen Hosp Campus,Crew Rd, Edinburgh EH4 2XU, Scotland
1 shared publicationDavid S. Morrison
Univ Glasgow, Sch Hlth & Wellbeing, Clarice Pears Bldg, 90 Byres Rd, Glasgow G12 8TB, Scotland
1 shared publicationFrancis A Carey
Department of Pathology, Ninewells Hospital and Medical School, Dundee, UK
1 shared publication- Gavin R. C. Clark
Public Health Scotland Edinburgh UK
1 shared publication Gavin R.C. Clark
Publ Hlth Scotland, Gyle Sq,1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland
1 shared publication
Latest Publications
- 6 September 2024
- Published by Elsevier in Journal of Cancer Policy
- Vol. 42, 100502
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
- 6 September 2024
- Published by Elsevier in Journal of Cancer Policy
- Vol. 42, 100502
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
- Open Access
- 19 July 2023
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 31 (1) , 21-27
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality
Objective: To compare interval cancer proportions (ICP) in the faecal immunochemical test (FIT)-based Scottish Bowel Screening Programme (SBoSP) with the former guaiac faecal occult blood test (gFOBT)-based SBoSP and investigate associations between interval cancer (IC) and faecal haemoglobin concentration (f-Hb) threshold, sex, age, deprivation, site, and stage. Methods: The ICP data from first year of the FIT-based SBoSP and the penultimate year of the gFOBT-based SBoSP were compared in a prospective cohort design. Results: With FIT, 801 colorectal cancers (CRCs) were screen detected (SDC), 802 were in non-participants, 548 were ICs, 39 were colonoscopy missed and 72 were diagnosed after incomplete screening; with gFOBT: 540, 904, 556, 45, and 13, respectively. FIT had a significantly higher proportion of SDC compared to IC than gFOBT. For FIT and gFOBT, ICP was significantly higher in women than men. As f-Hb threshold increased, ICP increased and, for any f-Hb threshold for men, a lower threshold was required for comparable ICP in women. In Scotland, the current threshold of ≥80 µg Hb/g faeces would have to be lowered to ≥40 µg Hb/g faeces for women to achieve sex equality for ICP. In the FIT-based SBoSP, there were four times as many stage I SDC than IC. This was reversed in advanced stages, with twice as many stage IV CRC diagnosed as IC versus SDC. Conclusions: Reducing the numbers of IC requires lowering the f-Hb threshold. Using different f-Hb thresholds for women and men could eliminate the sex disparity, but with additional colonoscopy.
- 19 July 2023
- Published by SAGE Publications in Journal of Medical Screening
- Vol. 31 (1) , 21-27
Open AccessInterval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality
Objective: To compare interval cancer proportions (ICP) in the faecal immunochemical test (FIT)-based Scottish Bowel Screening Programme (SBoSP) with the former guaiac faecal occult blood test (gFOBT)-based SBoSP and investigate associations between interval cancer (IC) and faecal haemoglobin concentration (f-Hb) threshold, sex, age, deprivation, site, and stage. Methods: The ICP data from first year of the FIT-based SBoSP and the penultimate year of the gFOBT-based SBoSP were compared in a prospective cohort design. Results: With FIT, 801 colorectal cancers (CRCs) were screen detected (SDC), 802 were in non-participants, 548 were ICs, 39 were colonoscopy missed and 72 were diagnosed after incomplete screening; with gFOBT: 540, 904, 556, 45, and 13, respectively. FIT had a significantly higher proportion of SDC compared to IC than gFOBT. For FIT and gFOBT, ICP was significantly higher in women than men. As f-Hb threshold increased, ICP increased and, for any f-Hb threshold for men, a lower threshold was required for comparable ICP in women. In Scotland, the current threshold of ≥80 µg Hb/g faeces would have to be lowered to ≥40 µg Hb/g faeces for women to achieve sex equality for ICP. In the FIT-based SBoSP, there were four times as many stage I SDC than IC. This was reversed in advanced stages, with twice as many stage IV CRC diagnosed as IC versus SDC. Conclusions: Reducing the numbers of IC requires lowering the f-Hb threshold. Using different f-Hb thresholds for women and men could eliminate the sex disparity, but with additional colonoscopy.